HIT Consultant February 9, 2022
What You Should Know:
– Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples.
– The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic investors operating in the field and existing investors.
Scopio puts Peripheral Blood Smears front and center
Blood tests are among the most frequent medical procedures in the world, with billions conducted every year. For blood tests, a lab tech looking at the slide under a microscope can only see a tiny part of the sample at a time. A few...
Today's Sponsors
Today's Sponsor